The statement discusses the FDA's decision-making process regarding drug approvals, referencing public figures and media opinions. It argues for maintaining high drug approval standards while acknowledging existing compassionate use provisions.
- The statement aims to inform and clarify the FDA's actions, which aligns with the principle of doing no harm by supporting public health standards. [+1]Principle 1:I will strive to do no harm with my words and actions.
- It promotes understanding by explaining the rationale behind the FDA's decisions, fostering informed public discourse. [+1]Principle 3:I will use my words and actions to promote understanding, empathy, and compassion.
- The statement engages in constructive dialogue by addressing differing opinions and providing justification for the FDA's actions without personal attacks. [+1]Principle 4:I will engage in constructive criticism and dialogue with those in disagreement and will not engage in personal attacks or ad hominem arguments.